Related Experiment Video
Updated: Aug 6, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Design and synthesis of conformationally-constrained MMP inhibitors
M G Natchus1, M Cheng, C T Wahl
1Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA.
Researchers identified new matrix metalloprotease inhibitors with potencies influenced by specific chemical structures. The caprolactam ring and succinate group substitutions significantly impacted inhibitor effectiveness.
Area of Science:
- Medicinal Chemistry
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in various diseases, including cancer and arthritis.
- Developing potent and selective MMP inhibitors is a key therapeutic goal.
Purpose of the Study:
- To design and synthesize a novel series of conformationally constrained matrix metalloprotease inhibitors.
- To investigate the structure-activity relationships of these novel inhibitors.
Main Methods:
- Synthesis of a series of conformationally constrained compounds.
- Evaluation of inhibitor potencies against target matrix metalloproteases.
Main Results:
- Identification of a novel series of MMP inhibitors.
- Inhibitor potency was found to be highly dependent on the substitution patterns of the caprolactam ring.
- The succinate moiety's substitution pattern also significantly influenced inhibitor potency.
Conclusions:
- Conformationally constrained MMP inhibitors can be effectively designed.
- Specific structural modifications on the caprolactam ring and succinate moiety are critical for optimizing inhibitor potency.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:01Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026